You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 8, August 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Women's Health
 •Women's Health, Other
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Depression
 •Alert me on articles by topic

Depression Symptom Severity and Reported Treatment History in the Prediction of Cardiac Risk in Women With Suspected Myocardial Ischemia

The NHLBI-Sponsored WISE Study

Thomas Rutledge, PhD; Steven E. Reis, MD; Marian B. Olson, MS; Jane Owens, PhD; Sheryl F. Kelsey, PhD; Carl J. Pepine, MD; Sunil Mankad, MD; William J. Rogers, MD; C. Noel Bairey Merz, MD; George Sopko, MD; Carol E. Cornell, PhD; Barry Sharaf, MD; Karen A. Matthews, PhD; Viola Vaccarino, MD, PhD

Arch Gen Psychiatry. 2006;63:874-880.

Background  Depression is associated with clinical events and premature mortality among patients with established coronary artery disease (CAD). Typically, however, studies in this area focus only on baseline symptom severity and lack any data concerning symptom duration or symptom history.

Objectives  To describe and compare the relationships between 2 measures of depression—assessed in the form of depression symptom severity and reported treatment history—with atherosclerosis risk factors and major clinical events in a sample of women with suspected myocardial ischemia.

Design  Follow-up study of women who completed a diagnostic CAD protocol, including cardiac symptoms, coronary angiography, ischemic testing, and assessments of depression symptom severity and reported treatment history.

Setting  The Women's Ischemia Syndrome Evaluation (WISE), a National Heart, Lung, and Blood Institute (NHLBI)–sponsored multicenter study assessing cardiovascular function using state-of-the-art techniques in women referred for coronary angiography to evaluate chest pain or suspected myocardial ischemia.

Participants  Five hundred five women (mean age, 53.4 years) enrolled in WISE and followed up for a mean of 4.9 years.

Main Outcome Measures  Incidence of cardiac events, including myocardial infarction, stroke, and heart failure, and total mortality.

Results  Relative to those with no or less stable depression symptoms, women with elevated depression symptoms and a reported treatment history showed higher rates of smoking, hypertension, and poorer education and an increased incidence of death and cardiac events (multivariate-adjusted risk ratio, 3.1; 95% confidence interval, 1.5-6.3; P = .001).

Conclusions  Among women with suspected myocardial ischemia, a combination of depressive symptom severity and treatment history was a strong predictor of an elevated CAD risk profile and increased risk of cardiac events compared with those without depression or with only 1 of the 2 measured depression markers. These findings reinforce the importance of assessing mental health factors in women at elevated CAD risk. Focusing only on baseline depression symptom severity may provide an incomplete picture of CAD risk.


Author Affiliations: Departments of Psychiatry, VA San Diego Healthcare System and University of California, San Diego (Dr Rutledge); Departments of Medicine (Dr Reis), Epidemiology (Ms Olson and Dr Kelsey), and Psychiatry (Drs Owens and Matthews), University of Pittsburgh, Pittsburgh, Pa; Departments of Medicine, University of Florida, Gainesville (Dr Pepine), Allegheny General Hospital, Pittsburgh (Dr Mankad), University of Alabama at Birmingham (Dr Rogers), Cedars-Sinai Medical Center, Los Angeles, Calif (Dr Bairey Merz), National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Sopko), Rhode Island Hospital, Providence (Dr Sharaf), and Emory University, Atlanta, Ga (Dr Vaccarino); and Department of Psychology, University of Arkansas for Medical Sciences, Little Rock (Dr Cornell).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depression, the Metabolic Syndrome and Cardiovascular Risk
Vaccarino et al.
Psychosom. Med. 2008;70:40-48.
ABSTRACT | FULL TEXT  

Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia: The National Heart, Lung, and Blood Institute Sponsored WISE Study
Vaccarino et al.
J Am Coll Cardiol 2007;50:2044-2050.
ABSTRACT | FULL TEXT  

Heart Rate Variability in Acute Coronary Syndrome Patients With Major Depression: Influence of Sertraline and Mood Improvement
Glassman et al.
Arch Gen Psychiatry 2007;64:1025-1031.
ABSTRACT | FULL TEXT  

Depression Is a Risk Factor for Mortality After Myocardial Infarction: Fact or Artifact?
Dickens et al.
J Am Coll Cardiol 2007;49:1834-1840.
ABSTRACT | FULL TEXT  

How Can Practice-based Research Contribute to the Elimination of Health Disparities?
Rust and Cooper
J Am Board Fam Med 2007;20:105-114.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.